Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:CKT NASDAQ:CRDL NYSE:SMRT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCKTCricket Media GroupC$0.00C$0.07▼C$0.32N/AN/A607 shsN/ACRDLCardiol Therapeutics$1.32+0.8%$1.29$0.88▼$1.71$146.48M0.77428,121 shs281,334 shsSMRTSmartRent$1.29+5.3%$1.41$0.78▼$2.20$235.26M1.571.24 million shs1.42 million shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRDLCardiol Therapeutics+0.76%0.00%-12.58%+32.00%+24.53%SMRTSmartRent+5.76%+15.25%-12.29%-21.88%+54.63%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCKTCricket Media GroupC$0.00C$0.07▼C$0.32N/AN/A607 shsN/ACRDLCardiol Therapeutics$1.32+0.8%$1.29$0.88▼$1.71$146.48M0.77428,121 shs281,334 shsSMRTSmartRent$1.29+5.3%$1.41$0.78▼$2.20$235.26M1.571.24 million shs1.42 million shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRDLCardiol Therapeutics+0.76%0.00%-12.58%+32.00%+24.53%SMRTSmartRent+5.76%+15.25%-12.29%-21.88%+54.63%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCKTCricket Media Group 0.00N/AN/AN/ACRDLCardiol Therapeutics 2.33Hold$8.50543.94% UpsideSMRTSmartRent 1.67Reduce$1.408.95% UpsideCurrent Analyst Ratings BreakdownLatest FADL, CKT, SMRT, and CRDL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/18/2026SMRTSmartRent Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$2.00 ➝ $1.405/7/2026SMRTSmartRent Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026SMRTSmartRent Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/6/2026CRDLCardiol Therapeutics Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.003/27/2026SMRTSmartRent Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 5/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCKTCricket Media GroupN/AN/AN/AN/AN/AN/ACRDLCardiol TherapeuticsN/AN/AN/AN/A$0.16 per shareN/ASMRTSmartRent$152.33M1.63N/AN/A$1.20 per share1.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCKTCricket Media GroupN/AN/AN/AN/AN/AN/AN/AN/AN/ACRDLCardiol Therapeutics-$24.20M-$0.28N/AN/AN/AN/A-229.43%-165.60%N/ASMRTSmartRent-$60.56M-$0.13N/AN/AN/A-16.58%-10.61%-7.57%8/5/2026 (Estimated)Latest FADL, CKT, SMRT, and CRDL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/11/2026Q1 2026CRDLCardiol Therapeutics-$0.07-$0.07N/A-$0.07N/AN/A5/6/2026Q1 2026SMRTSmartRent-$0.02-$0.02N/A-$0.02$36.82 million$36.63 million3/30/2026Q4 2025CRDLCardiol Therapeutics-$0.09-$0.05+$0.04-$0.05N/AN/A3/4/2026Q4 2025SMRTSmartRent-$0.01-$0.02-$0.01-$0.02$36.31 million$33.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCKTCricket Media GroupN/AN/AN/AN/AN/ACRDLCardiol TherapeuticsN/AN/AN/AN/AN/ASMRTSmartRentN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCKTCricket Media GroupN/AN/AN/ACRDLCardiol TherapeuticsN/A4.394.39SMRTSmartRentN/A3.953.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCKTCricket Media GroupN/ACRDLCardiol Therapeutics12.49%SMRTSmartRent59.42%Insider OwnershipCompanyInsider OwnershipCKTCricket Media GroupN/ACRDLCardiol Therapeutics5.25%SMRTSmartRent2.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCKTCricket Media Group147,000N/AN/ANot OptionableCRDLCardiol Therapeutics20111.82 million105.95 millionNot OptionableSMRTSmartRent640192.84 million188.40 millionOptionableFADL, CKT, SMRT, and CRDL HeadlinesRecent News About These CompaniesSmartRent (NYSE:SMRT) Price Target Lowered to $1.40 at Keefe, Bruyette & WoodsMay 19, 2026 | americanbankingnews.comSmartRent (NYSE:SMRT) CEO Frank Martell Acquires 100,000 SharesMay 14, 2026 | insidertrades.comSmartRent (SMRT) price target decreased by 12.50% to 1.78May 14, 2026 | msn.comSmartRent Stock Dividends | NYSE:SMRT | BenzingaMay 13, 2026 | benzinga.comSmartRent Launches $10M Investment Program to Fuel Next-Level Innovation and Customer SuccessMay 13, 2026 | businesswire.comThe 5 most interesting analyst questions from SmartRent’s Q1 earnings callMay 13, 2026 | msn.comSmartRent Shareholders Approve Expanded Equity Incentive PlanMay 13, 2026 | tipranks.comSmartRent (SMRT) Poised For Growth With Rental Market Expansion and Financial StabilizationMay 12, 2026 | insidermonkey.comFrank Martell Acquires 50,000 Shares of SmartRent (NYSE:SMRT) StockMay 9, 2026 | insidertrades.comFrank Martell Purchases 50,000 Shares of SmartRent (NYSE:SMRT) StockMay 8, 2026 | marketbeat.comAnalysts Have Conflicting Sentiments on These Technology Companies: Marqeta (MQ), SmartRent (SMRT) and Verra Mobility (VRRM)May 8, 2026 | theglobeandmail.comSMRT Q1 deep dive: Sales productivity ramp and contract resets shape outlookMay 7, 2026 | msn.comSmartRent (NYSE:SMRT) Announces Quarterly Earnings ResultsMay 6, 2026 | marketbeat.comSmartRent SMRT Q1 2026 Earnings Call TranscriptMay 6, 2026 | finance.yahoo.comSmartRent, Inc. (SMRT) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comSmartRent’s (NYSE:SMRT) Q1 CY2026 sales beat estimates but stock dropsMay 6, 2026 | msn.comSmartRent Insider Trading Activity | NYSE:SMRT | BenzingaMay 1, 2026 | benzinga.comSmartRent (SMRT) Launches VAR Program to Expand Into SMB Multifamily Housing MarketMay 1, 2026 | finance.yahoo.comSmartRent (SMRT) Expected to Announce Quarterly Earnings on WednesdayApril 29, 2026 | marketbeat.comSmartRent Launches Value-Added Reseller ProgramApril 27, 2026 | businesswire.comSmartRent to Report First Quarter 2026 Financial Results on May 6, 2026April 16, 2026 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFADL, CKT, SMRT, and CRDL Company DescriptionsCricket Media Group CVE:CKTCricket Media Group Ltd. (Cricket Media) is a United States-based education media company. The Company provides content on a learning network for children, families and teachers across the world. Its media brands for toddlers to teens include Babybug, Ladybug, Cricket and Cobblestone. The Company's products include magazines under categories, such as Ask, Cicada, Babybug, Click, Cricket, Cobblestone, Dig, Faces, Ladybug, Muse and Spider; educational toys; books; teacher guides; content library, and Story Bug application. Its Web-based K12 tools for school and home include the ePals community and virtual classroom for global collaboration, as well as In2Books, a Common Core eMentoring program that builds reading, writing and critical thinking skills. It serves teachers, students and parents in over 200 countries and territories through its platform and NeuPals, its joint venture with China-based information technology services company Neusoft.Cardiol Therapeutics NASDAQ:CRDL$1.32 +0.01 (+0.76%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.32 +0.00 (+0.30%) As of 05/22/2026 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.SmartRent NYSE:SMRT$1.28 +0.07 (+5.33%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$1.28 -0.01 (-0.70%) As of 05/22/2026 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SmartRent, Inc., an enterprise software company, provides an integrated smart home operating system to residential property owners and operators, homebuilders, institutional home buyers, developers, and residents in the United States. The company's products and solutions include smart apartments and homes, access control for buildings, common areas, and rental units, asset protection and monitoring, parking management, self-guided tours, and community and resident Wi-Fi. It also offers professional services to customers, which include training, installation, and support services. The company was founded in 2017 and is headquartered in Scottsdale, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
